Ligand · QCT
QCT · 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside
QCT, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside (C21 H20 O11, 448.4 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (4 PDB entries). Every binding site with its residues…
- Component
- QCT
- Formula
- C21 H20 O11
- Class
- ligand
- Structures
- 4
- PDB entries
- 4
Binding sites
QCT in 4 structures; the first of them:
- 8DSE · Human NAMPT in complex with substrate NAM and activator quercitrin · QCT A1005 · binds TYR188, LYS189, HIS191, PHE193, ASP219, TYR240, SER241, VAL242 and 12 more
- 8DSH · Human NAMPT in complex with quercitrin and AMPcP · QCT A1302 · binds TYR188, LYS189, HIS191, PHE193, ASP219, TYR240, SER241, VAL242 and 12 more
- 8EQ5 · Crystal structure of the N-terminal kinase domain of RSK2 in complex with SPRED2 (131-160) · QCT A401 · binds ILE52, SER78, PHE79, VAL82, ALA98, LYS100, LEU102, VAL131 and 10 more
- 8R58 · The RSK 2 N-terminal kinase domain in complex with BMF (1-19) · QCT A401 · binds ILE50, ILE52, GLN76, SER78, PHE79, VAL82, ALA98, LYS100 and 12 more
Residues it binds most
ILE 6, LEU 2, VAL 6, ALA 6, SER 6, PHE 6, PRO 4, TYR 4, ASP 6, GLU 6 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.